Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
17 October 2025
Dear Shareholders
Annual General Meeting
Orbital Corporation Limited ACN 009 344 058 (Orbital or Company) advises that its 2025 Annual General Meeting
is scheduled to be held in person at 10:00 (AWST) on Thursday, 20 November 2025 at Stirling Leisure Centre, 38
Ashbury Crescent, Mirrabooka WA 6061 (Meeting).
In the interest of efficiency and reducing the environmental impact of printing and shipment, and as permitted by
the Corporations Act 2001 (Cth), the Company will not be dispatching physical copies of the Notice of Meeting
unless the shareholder has made a valid election to receive documents in hard copy.
The Notice of Meeting can be viewed and downloaded from the link set below.
A Proxy Form in relation to the Meeting is included with this letter. The Company strongly encourages Shareholders
to lodge a directed proxy form prior to the Meeting and register their attendance to the Meeting should they wish to
attend. Completed Proxy Forms must be returned to and received by the Company’s Share Registry, MUFG
Corporate Markets (AU) Limited, by 10:00am (AWST) on Tuesday, 18 November 2025, in accordance with the
instructions on the Proxy Form.
Questions should also be submitted in advance of the Meeting as this will provide management with the best
opportunity to prepare for the meeting, for example by preparing answers in advance to Shareholders' questions.
Voting and questions may also be submitted during the Meeting.
Please find below the link to important Meeting documents:
Notice of Meeting and Explanatory Statement: https://orbitaluav.com/investors/www.orbitaluav.com/investors
Alternatively, a complete copy of the document is available from the ASX announcements platform.
If you have nominated an email address and have elected to receive electronic communications from the Company,
you will receive an email to your nominated email address with a link to an electronic copy of the important Meeting
documents.
In order to receive electronic communications from the Company in the future, please update your Shareholder
details online at https://au.investorcentre.mpms.mufg.com and Register as a member with your unique shareholder
identification number and postcode (or country for overseas residents).
If you are unable to access any of the important Meeting documents online, please contact the Company Secretary
on +61 8 9441 2135 or via email at mwege@orbitalcorp.com.au.
If it becomes necessary or appropriate to make alternative arrangements to those set out in the Company’s Notice
of Meeting, the Company will notify Shareholders accordingly via the Company’s website at https://orbitaluav.com/
and the Company’s ASX Announcement Platform at www.asx.com.au (ASX: OEC).
This announcement is authorised for market release by the Board of Orbital Corporation Limited.
Sincerely,
Mark Wege
CFO | Company Secretary
Orbital Corporation Limited
1
ORBITAL CORPORATION LIMITED
ABN 32 009 344 058
Notice of 2025 Annual General Meeting
10:00am (AWST), Thursday 20 November 2025
Stirling Leisure Centre
38 Ashbury Crescent
Mirrabooka WA 6061
Orbital Corporation Limited
NOTICE OF 2025 ANNUAL GENERAL MEETING
2
Dear Shareholder
It is my pleasure to invite you to attend Orbital’s Annual General Meeting
(AGM) to be held at 10.00am Australian Western Standard Time
(AWST) on Thursday 20 November 2025 at the Stirling Leisure Centre
38 Ashbury Crescent, Mirrabooka WA 6061 (Meeting).
As a Shareholder your participation at the Meeting is important. The
Meeting is an opportunity to engage directly with Orbital’s Board and
senior management team and I encourage you to attend.
US Department of Defense UAV strategies and associated procurement
policies are currently in transition.
In June 2025 the US President signed Executive Order 14307, aiming
to enhance the United States' leadership in drone technology by
accelerating the integration and commercialisation of drones into the
national airspace. This includes investment of USD 150 billion in UAV
funding through 2032 across military and commercial segments.
This transition will take some time to be implemented by the US
Department of Defense, and as such the Board cannot fully assess the
impact on the Company at this time.
However, the Company is well positioned to meet the increased demand
expected to flow through from this decision as we are fully aligned to
UAS compliance requirements and have an existing manufacturing
facility in the US that can be re-activated within the next 12-months.
The rapidly evolving UAV market demands include:
• Increased payload requirements creating strong demand for
higher-capacity engines across both military and commercial UAV
markets;
• Vertical take-off and landing (VTOL) configurations in both military
and commercial market sectors requiring high-voltage battery
charging, further accelerating the shift toward more powerful
engines; and
• Beyond Visual Line of Sight (BVLOS) regulations that are driving
the need for increased system safety and reliability, accelerating
the adoption toward heavy fuels and military-grade performance
standards in the commercial market.
An electronic copy of the Company’s 2025 Annual Report is available to
download or view on Orbital’s website at: https://orbitaluav.com/. Hard
copies have been sent to those Shareholders who previously elected to
receive the report in this format.
This Notice of Meeting details the items of business to be conducted at
the AGM. Your Directors believe that each of the resolutions is in the
best interests of the Company and its Shareholders.
Voting on the resolutions at the Meeting is important and if you are not
able to attend, I encourage you to exercise your voting rights by
completing and returning the enclosed Proxy Form. If you nominate a
proxy, please carefully consider the related comments in this Notice.
Completed Proxy Forms must be returned to and received by the
Company’s Share Registry, MUFG Corporate Markets (AU) Limited, by
10:00am (AWST) on Tuesday 18 November 2025. This can be done
either by posting the enclosed form or lodging it online at
https://au.investorcentre.mpms.mufg.com
On behalf of the Board and management team I look forward to your
company at the Meeting.
Yours faithfully
Kyle Abbott
Chair
17 October 2025
The 2025 Annual General Meeting of Orbital Corporation Limited ACN 009 344 058 (Orbital or the
Company) will be held at 10:00am (AWST) on Thursday 20 November 2025 at the Stirling Leisure
Centre, 38 Ashbury Crescent, Mirrabooka WA 6061.
Orbital Corporation Limited
NOTICE OF 2025 ANNUAL GENERAL MEETING
3
Items of Business (Items)
Shareholder
Approval
Voting
Restrictions
and Further
Details
ORDINARY BUSINESS
1. CHAIR & CEO ADDRESS The Chair and CEO will provide a presentation on the
performance of the Company during the financial year
ended 30 June 2025 and outline the strategic
operational activities of the Company.
Not applicable 5
2. DISCUSSION OF FINANCIAL
STATEMENTS AND REPORTS
To receive and consider the Financial Report,
Directors’ Report and Auditor’s Report for the year
ended 30 June 2025.
Not applicable 5
3. REMUNERATION REPORT To adopt the Remuneration Report for the year ended
30 June 2025.
Non-binding 5
4. RE-ELECTION OF DIRECTOR –
MR STEVE GALLAGHER
That, for the purposes of Listing Rule 14.4, clause
7.3(c) of the Constitution and for all other purposes, Mr
Steve Gallagher be re-elected as a Director.
Ordinary
resolution
5
5. ELECTION OF DIRECTOR – MR
ANDREW MILLS
That, for the purposes of Listing Rule 14.4, clause 7.3(j)
of the Constitution and for all other purposes, Mr
Andrew Mills, having been appointed to the Board
since the last annual general meeting of the Company,
ceases to hold office and, being eligible, is elected as
a Director.
Ordinary
resolution
6
SPECIAL BUSINESS
6. RATIFY THE ISSUE OF
PLACEMENT SHARES UNDER
LISTING RULE 7.1
That, pursuant to and in accordance with Listing Rule
7.4 and for all other purposes, Shareholders approve
and ratify the prior issue of 14,285,715 Shares under
Listing Rule 7.1 on the terms and conditions in the
Explanatory Notes.
Ordinary
resolution
6
7. ADDITIONAL CAPACITY TO
ISSUE EQUITY SECURITIES
That, pursuant to and in accordance with Listing Rule
7.1A and for all other purposes, Shareholders
authorise and approve the issue of equity securities (as
defined in the Listing Rules, Equity Securities) of up
to 10% of the issued capital of the Company (at the
time of the issue) calculated in accordance with the
formula prescribed in Listing Rule 7.1A.2 and on the
terms and conditions in the Explanatory Notes.
Special
resolution
7
Orbital Corporation Limited
NOTICE OF 2025 ANNUAL GENERAL MEETING
4
VOTING
Voting Entitlement
The Company’s shareholders (Shareholders) recorded on the Company’s
register of members at 4:00pm (AWST) on Tuesday 18 November 2025
(Voting Entitlement Date) will be entitled to vote on Items at the Company’s
2025 annual general meeting (Meeting).
Becoming a Shareholder
Persons who become registered Shareholders between the date of this
notice of meeting (Notice) and the Voting Entitlement Date and wish to vote
at the Meeting by proxy should call +61 1300 554 474 and request an
additional personalised voting form.
Persons who become beneficial Shareholders between the date of this
Notice and the Voting Entitlement Date and wish to vote at the Meeting by
proxy should contact their broker or intermediary for instructions on how to
do so.
Voting Procedure
Under the Company’s constitution as at the date of this Notice
(Constitution), each poll will be conducted as directed by the chair of the
Meeting (the Chair).
Shareholders can vote in one of two ways:
• by attending the Meeting and voting; or
• by appointing a proxy to attend and vote on their behalf.
Shareholders are asked to arrive at the venue 15 minutes prior to the time
designated for the Meeting, if possible, so that the Company may check their
Shareholding against the Company’s share register and note attendances.
Voting Restrictions
The voting prohibitions under the Corporations Act 2001 (Cth) (Corporations
Act) and voting exclusions under the ASX Listing Rules (Listing Rules) for
each Item are set out in the Explanatory Notes to this Notice.
PROXY FORMS
Proxy Form
Enclosed with this Notice is a personalised proxy form (Proxy Form). The
Proxy Form allows Shareholders who are not attending the Meeting to
appoint a proxy to vote on their behalf.
If you hold fully paid ordinary shares in the capital of the Company (Shares)
in more than one capacity, please complete the Proxy Form that is relevant
to each holding.
Appointing proxies
Shareholders who are entitled to attend and vote at the Meeting, may appoint
a proxy to act generally at the Meeting and to vote on their behalf.
A proxy need not be a Shareholder of the Company.
A Shareholder entitled to attend and vote can appoint up to two proxies, and
should specify the proportion or number of votes each proxy is appointed and
authorised to exercise. If no proportion or number is specified, each proxy
may exercise half of the Shareholder’s votes. If you wish to appoint two
proxies please call +61 1300 554 474 and request an additional Proxy Form.
A corporate Shareholder or proxy must appoint a person as its corporate
representative.
Undirected proxies
Any proxy given to:
• a member of the Company’s key management personnel (those
persons having authority and responsibility for planning, directing and
controlling the activities of the Company and its consolidated group,
directly or indirectly, including any director (whether executive or
otherwise) of the Company (Directors) or of an entity within the
consolidated group) (Key Management Personnel), other than the
Chair; or
• their closely related parties (including a spouse, child, dependent or
other close family members, as well as any companies they control)
(Closely Related Parties),
for Item 3 will not be counted unless Shareholders specify how the proxy is
to vote.
Any undirected proxy given to the Chair for Item 3 by a Shareholder entitled
to vote on such Item will be voted by the Chair in favour of the Item, in
accordance with the express authorisation on the Proxy Form (even though
Items 3 is connected directly or indirectly with the remuneration of members
of Key Management Personnel). The Chair intends to vote all valid undirected
proxies for all Items in favour of those Items.
Power of attorney and corporate representatives
If the Proxy Form is signed by an attorney, the power of attorney or a certified
copy of it must be sent with the Proxy Form.
A body corporate member may elect to appoint a representative, rather than
appoint a proxy. Where a body corporate appoints a representative, written
proof of the representative’s appointment must be lodged with, or presented
to, the Company before the Meeting.
A body corporate appointed as a proxy must also lodge a certificate of
appointment of a corporate representative.
The appointment of a corporate representative must be received by the
Company before the Meeting or at the registration desk on the day of the
Meeting. Certificates of appointment of corporate representatives are
available at MUFG Corporate Markets (AU) Limited’s website
https://www.mpms.mufg.com/en/for-individuals/au/shareholders/forms/ –
then submit the form in accordance with the instructions on the ‘Appointment
of Corporate Representation’ form,
or on request by calling +61 1300 554 474.
LODGING PROXY FORMS
Deadline
Proxy Forms must be received by 10:00am (AWST) on Tuesday 18
November 2025.
How to lodge Proxy Forms
You can lodge your Proxy Form with the Company by:
Online: at https://au.investorcentre.mpms.mufg.com
Mail: to Orbital Corporation Limited C/- MUFG Corporate Markets (AU)
Limited, Locked Bag A14 Sydney South NSW 1235 Australia.
Delivery: to MUFG Corporate Markets (AU) Limited* Parramatta Square,
Level 22, Tower 6, 10 Darcy Street Parramatta NSW 2150
*During business hours Monday to Friday (9:00am - 5:00pm)
Facsimile: +61 2 9287 0309
Further details on how to lodge your Proxy Form can be found on the reverse
side of the Proxy Form.
ENQUIRIES
If you have any questions about this Notice or your Proxy Form please
contact the Company’s share registry, MUFG Corporate Markets (AU)
Limited, by calling +61 1300 554 474.
By order of the Board of Directors
Mark Wege
Company Secretary
17 October 2025
Orbital Corporation Limited
EXPLANATORY NOTES
5
ITEM 1 CHAIR’S ADDRESS
The Chair will address the Meeting and provide a presentation on the
performance of the Company during the financial year ended 30 June 2025
and describe the strategic and operational activities of the Company. The
Chair will also allow time at the end of the Meeting to respond to questions
by Shareholders.
ITEM 2 DISCUSSION OF FINANCIAL STATEMENTS AND
REPORTS
In accordance with the Corporations Act, Shareholders will have a
reasonable opportunity to ask questions or make comments on the
Company’s Financial Report, Directors’ Report and Auditor’s Report for the
year ended 30 June 2025.
The Company’s auditor, Nexia Perth Audit Services Pty Ltd will be present at
the Meeting and Shareholders will have an opportunity to ask the auditor
questions in relation to the conduct of the audit, the Auditor’s Report, the
Company’s accounting policies and the independence of the auditor.
The auditor will also respond to any written questions provided these are
submitted to the Company no later than five business days prior to the
Meeting.
There is no requirement for Shareholders to approve the Company’s
Financial Report, Directors’ Report and Auditor’s Report.
A copy of the Company’s 2025 Annual Report, which includes the Company’s
Financial Report, Directors’ Report and Auditor’s Report is available on the
Company’s website: https://www.orbitaluav.com/.
ITEM 3 REMUNERATION REPORT
Background
The Remuneration Report for the financial year ended 30 June 2025 is
included in the Company’s 2025 Annual Report and sets out the Company’s
remuneration arrangements for Directors and executive staff.
The Chair will allow a reasonable opportunity for Shareholders to ask
questions about or make comments on the Remuneration Report at the
Meeting. Shareholders will then be asked to vote on the Remuneration
Report.
The vote is advisory only and does not bind the Company or its Directors.
The Company’s board (Board) will consider the outcome of the vote and
comments made by Shareholders on the Remuneration Report at the
meeting when reviewing the Company’s remuneration policies.
No spill resolution
If at least 25% of votes that are cast are voted against the adoption of the
Company’s Remuneration Report at two consecutive annual general
meetings, Shareholders must vote on whether the Board (other than any
managing director) should go up for re-election.
At the Company’s 2024 annual general meeting, less than 25% of the votes
cast on the resolution to adopt the 2024 Remuneration Report were voted
against the resolution. Accordingly no spill resolution will be held at this
Meeting.
Voting prohibition statement
In accordance with the Corporations Act, a vote on this Item must not be cast
(in any capacity) by or on behalf of any of the following persons:
• a member of the Key Management Personnel details of whose
remuneration are included in the Remuneration Report; or
• a Closely Related Party of such a member.
However, a person described above may cast a vote on this Item if the vote
is not cast on behalf of a person described in subparagraphs (a) or (b) above
and either:
• the person is appointed as a proxy by writing that specifies the way the
proxy is to vote on this Item; or
• the person is the Chair and the appointment of the Chair as proxy does
not specify the way the proxy is to vote on this Item but expressly
authorises the Chair to exercise the proxy, even if this Item is connected
directly or indirectly with the remuneration of a member of the Key
Management Personnel.
Board recommendation
The Board abstains, in the interests of good corporate governance, from
making a recommendation in relation to the adoption of the Remuneration
Report.
The Chair intends to vote undirected proxies in favour of Item 3 in
accordance with the express authorisation on the Proxy Form.
ITEM 4 RE-ELECTION OF DIRECTOR – MR STEVE
GALLAGHER
Mr Steve Gallagher was last re-elected to the Board on 16 November 2022.
In accordance with Listing Rule 14.4 and clause 7.3(c) of the Constitution, Mr
Gallagher will retire and being eligible, offer himself for re-election as this is
the third annual general meeting since he was last elected. His relevant skills
and experience and other ASX listed directorships are summarised below.
Mr Steve Gallagher
BENG (HON) BCOM MAICD
Term Initially appointed to the Board on 12 April 2017
Independent Mr Gallagher is an independent non-executive
Director.
Skills and
experience
Mr Gallagher is Principal of Agere Pty Ltd, an advisory
and investment company drawing on his capability
and professional networks established over 30 years
as a CEO, director, and executive general manager of
global businesses with companies including Vix
Technology Ltd, Siemens AG, Landis & Gyr AG and
CCRTT Ltd.
Mr Gallagher has operated in various business sectors
including industrial automation, building technology
and power systems, having spent 15 years living and
working in Asia (China, Hong Kong and Singapore)
and Europe (Switzerland).
Mr Gallagher is currently a non-executive director and
chair of ICM Mobility Ltd (an investment holding
company for mobility services companies in
transportation including Vix Technology Ltd, Littlepay
Ltd, Kuba Payments Ltd, Snapper Services Ltd,
Unwire Ltd), Transact1 Pty Ltd (a financial services
provider for cash management optimisation), DTI
Group Ltd (an ASX listed passenger information and
surveillance business).
Other ASX
listed
directorships
Mr Gallagher also serves as a non-executive director
of DTI Group Ltd (ASX: DTI) (originally appointed as a
director in October 2018).
Interests in the
Company
412,502 Shares.
If Item 4 is passed, Mr Gallagher will be re-elected as a Director.
If Item 4 is not passed, Mr Gallagher will cease to be a Director at the
conclusion of the Meeting.
Orbital Corporation Limited
EXPLANATORY NOTES
6
Board recommendation
The Board (other than Mr Gallagher who has an interest in Item 4) believe
that the re-election of Mr Gallagher is in the best interests of the
Company, as his skills and experience align with the Company’s strategic
direction, and unanimously recommend that Shareholders vote in favour
of the re-election of Mr Gallagher.
The Chair intends to vote undirected proxies in favour of Item 4.
ITEM 5 ELECTION OF DIRECTOR – ANDREW MILLS
In accordance with Listing Rule 14.4 and clause 7.3(j) of the Constitution, a
director appointed by the Board as an addition to the board must not hold
office (without re-election) past the next annual general meeting following
the director's appointment.
Mr Mills, an executive Director, retires in accordance with clause 7.3(j) of
the Constitution and Listing Rule 14.4 and offers himself for re-election. Mr
Mills joined the Board in January 2025. He is an executive Director.
Mr Andrew Mills
BSc (HON) MAICD
Term Appointed to the Board on 9 January 2025.
Independent Mr Mills is an executive Director.
Skills and
experience
Mr Mills has a bachelor’s degree in applied chemistry
and has 25 years’ experience within automotive and
aerospace industries. Prior to joining Orbital in 2019
Mr Mills held senior leadership roles with BAE
Systems UK and HELLA New Zealand.
Mr Mills previously oversaw Orbital Operations as the
general manager of operations and was interim chief
executive officer from September 2023 to March 2024.
Mr Mills’ significant technical, operational and industry
expertise, combined with his oversight of Orbital’s
aerospace disciplines, was crucial in maturing
Orbital’s manufacturing capability within the
aerospace industry.
Other ASX
listed
directorships
Nil.
Interests in the
Company
3,461 Shares
1,000,000 Options
If Item 5 is passed, Mr Mills will be elected as a Director.
If Item 5 is not passed, Mr Mills will cease to be a Director at the conclusion
of the Meeting.
Board recommendation
The Board (other than Mr Mills who has an interest in Item 5) believe
that the election of Mr Mills is in the best interests of the Company, as
his skills and experience align with the Company’s strategic direction,
and unanimously recommend that Shareholders vote in favour of the
election of Mr Mills.
The Chair intends to vote undirected proxies in favour of Item 5.
ITEM 6 RATIFY THE ISSUE OF PLACEMENT SHARES
UNDER LISTING RULE 7.1
Background
In August 2025, the Company undertook a placement to raise $3 million
(before costs) through the issue of 14,285,714 new Shares at an issue price
of $0.21 per Share (Placement Shares) (the Placement). Refer to the
Company's ASX announcement dated 21 August 2025 for further information
on the Placement.
All Placement Shares were issued pursuant to the Company's placement
capacity under Listing Rule 7.1 without Shareholder approval.
Item 6 seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the
issue of the Placement Shares issued pursuant to the Company's placement
capacity under Listing Rule 7.1.
Item 6 is an ordinary resolution.
The Chair intends to exercise all available undirected proxies in favour of
Item 6.
Voting exclusion statement
The Company will disregard any votes cast in favour of this Item by or on
behalf of a person who participated in the Placement or an associate of those
persons.
However, this does not apply to a vote cast in favour of this Item by:
• a person as proxy or attorney for a person who is entitled to vote on this
Item, in accordance with directions given to the proxy or attorney to vote
on this Item that way; or
• the Chair as proxy or attorney for a person who is entitled to vote on this
Item, in accordance with a direction given to the Chair to vote on this Item
as the Chair decides; or
• a holder acting solely in a nominee, trustee, custodial or other fiduciary
capacity on behalf of a beneficiary provided the following conditions are
met:
o the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of
a person excluded from voting, on this Item; and
o the holder votes on this Item in accordance with directions given
by the beneficiary to the holder to vote in that way.
Listing Rule 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1
limits the amount of Equity Securities that a listed company can issue without
the approval of its shareholders over any 12-month period to 15% of the fully
paid ordinary securities it had on issue at the start of that period (15%
Placement Capacity).
Listing Rule 7.4 provides that if the Company in general meeting ratifies the
previous issue of Equity Securities made pursuant to Listing Rule 7.1 (and
provided that the previous issue did not breach Listing Rule 7.1) those Equity
Securities will be deemed to have been made with Shareholder approval for
the purpose of Listing Rule 7.1.
The Company wishes to retain as much flexibility as possible to issue
additional Equity Securities into the future up to the 15% Placement Capacity
set out in Listing Rule 7.1 without the requirement to obtain prior Shareholder
approval.
If Item 6 is passed, the Placement Shares will be excluded in calculating the
Company's 15% Placement Capacity in Listing Rule 7.1, effectively
increasing the number of Equity Securities the Company can issue without
Shareholder approval over the 12-month period from the date of issue.
If Item 6 is not passed, the Placement Shares will be included in calculating
the Company's 15% Placement Capacity in Listing Rule 7.1, effectively
decreasing the number of Equity Securities the Company can issue without
Shareholder approval over the 12-month period from the date of issue.
Orbital Corporation Limited
EXPLANATORY NOTES
7
Specific Information required by Listing Rule 7.5
The following information must be provided to Shareholders for the purposes
of obtaining Shareholder approval:
Identity of
Shareholders
The Placement Shares were issued to institutional and
sophisticated investors identified by Peloton Capital Pty
Ltd (who acted as lead manager to the Placement) and the
Company, none of whom were a related party of the
Company, a member of the Key Management Personnel,
a substantial shareholder of the Company, or an adviser of
the Company or an associate of any of those persons.
Type of
securities
The Placement Shares are fully paid ordinary shares in the
capital of the Company and rank equally in all respects with
the Company’s existing Shares on issue.
Date of issue The Placement Shares were issued on 28 August 2025.
Issue price The Placement Shares were issued at an issue price of
$0.21 per Share, raising a total of approximately $3 million
(before costs).
Indicative use
of funds
Funds raised from the issue of the Placement Shares are
intended to upgrade and increase the Company’s
manufacturing and test facilities, increase global business
development activities and accelerate the development of
new product offers.
Terms of the
agreement
The Placement Shares were issued pursuant to placement
letters pursuant to which institutional and sophisticated
investors agreed to participate in the Placement. The key
terms of the placement letters have been disclosed in this
Notice.
Voting
exclusion
statement
A voting exclusion statement is included above.
Board recommendation
The Board unanimously recommends that Shareholders vote in favour
of Item 6.
The Chair intends to vote undirected proxies in favour of Item 6.
ITEM 7 ADDITIONAL CAPACITY TO ISSUE EQUITY
SECURITIES
General
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1
limits the amount of Equity Securities that a listed company can issue without
the approval of its shareholders over any 12 month period to 15% of the fully
paid ordinary securities it had on issue at the start of that period.
Listing Rule 7.1A enables eligible entities to issue Equity Securities up to
10% of its issued share capital through placements over a 12-month period
after the annual general meeting (being the 10% Placement Facility). The
10% Placement Facility is in addition to the Company's 15% Placement
Capacity under Listing Rule 7.1.
An eligible entity for the purposes of Listing Rule 7.1A is an entity that is not
included in the S&P/ASX 300 Index and has a market capitalisation of $300
million or less. The Company is an eligible entity.
The Company is seeking Shareholder approval by way of a special resolution
to have the ability to issue Equity Securities under the 10% Placement
Facility. The number of Equity Securities to be issued under the 10%
Placement Facility will be determined in accordance with the formula
prescribed in Listing Rule 7.1A.
If Item 7 is passed, the effect will be that the Company will be able to issue
Equity Securities under the 10% Placement Facility in addition to the
Company’s 15% Placement Capacity under Listing Rule 7.1.
If Item 7 is not passed, the effect will be that the Company will not be able to
issue any Equity Securities under the 10% Placement Facility and will have
to rely upon its 15% Placement Capacity under Listing Rule 7.1 for the issue
of Equity Securities.
Item 7 is a special resolution and therefore requires approval of 75% of the
votes cast by Shareholders present and eligible to vote (in person, by proxy,
by attorney or, in the case of a corporate Shareholder, by a corporate
representative).
Voting exclusion statement
The Company will disregard any votes cast in favour of Item 7 by or on behalf
of a person who is expected to participate in, or who will obtain a material
benefit as a result of, the proposed issue (except a benefit solely by reason
of being a holder of ordinary
Share your feedback
Discover